Loading clinical trials...
Loading clinical trials...
Prospective Phase I/II Study to Evaluate Effects of Sodium Phenylbutyrate in Pre-symptomatic Infants With Spinal Muscular Atrophy
Conditions
Interventions
Sodium phenylbutyrate
Locations
1
United States
University of Utah
Salt Lake City, Utah, United States
Start Date
July 1, 2007
Primary Completion Date
December 1, 2013
Completion Date
December 1, 2013
Last Updated
February 28, 2025
NCT05866419
NCT06839469
NCT06955897
NCT06321965
NCT07223489
NCT07332702
Lead Sponsor
University of Utah
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions